National

PIB’S BULLETIN ON COVID-19

COVID TRACKER/PIB

Posted On: 13 MAY 2021, Delhi

Advertisements

IN PUBLIC INTEREST

*Cover your face with masks to prevent transmission of droplets carrying coronavirus
*Exercise social distancing
*Wash your hands frequently
*Sanitize your hands

STAY HOME & STAY SAFE!

 

India’s Cumulative Vaccination Coverage exceeds 17.72 CroreMore than Half a Crore patients served by the National Telemedicine Service (eSanjeevani) during the COVID-19 PandemicDCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years

#Unite2FightCorona

#IndiaFightsCorona

PRESS INFORMATION BUREAU

MINISTRY OF INFORMATION AND BROADCASTING

GOVERNMENT OF INDIA

India’s Cumulative Vaccination Coverage exceeds 17.72 Crore

  • 4,31,285 beneficiaries of the age group 18-44 years received their first dose of COVID vaccine in the last 24 hours and cumulatively 34,80,618 across 30 States/UTs since the start of phase-3 of vaccination drive. Table below shows the cumulative vaccine doses administered to 18-44 years age group till now.
  • India’s cumulative recoveries stand at 1,97,34,823 today. The National Recovery Rate is 83.26%.
  • The National Mortality Rate currently stands at 1.09%.

For Details : https://pib.gov.in/PressReleasePage.aspx?PRID=1718217

More than Half a Crore patients served by the National Telemedicine Service (eSanjeevani) during the COVID-19Pandemic

  • Daily, over 1500 doctors serve patients remotely through eSanjeevani telemedicine platform
  • Few States working towards rolling out special Home Isolation OPDs wherein patients can be screened remotely for COVID-19 by final year MBBS students

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1718221

DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years

The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on 12.05.2021.

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1718192

Update on Ventilators Supplied under PM CARES

“Made in India” Ventilators have strengthened Infrastructure of Hospitals for Effective COVID management. All Technical Assistance being provided by Manufacturers for their Glitch-free Operation.

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1718183

Bhubaneswar Airport ensures seamless delivery of medical essentials to support the fight against Covid-19

Total 156 empty oxygen tankers, 526 oxygen concentrators and 140 oxygen cylinders transported.
 

For Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1718233

PIB FACT CHECK

Categories: National

Tagged as: ,

Leave a Reply